Publications by authors named "Huiqian Peng"

Claim this Profile
N
Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD Salvage Synthesis.
Siyi Zhang, Zhen Li, Bo Li, Zhiyi Li, Huiqian Peng, Jialiang Peng

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel -phenyl-2-(aniline) benzamide hydrochloride salt development for colon cancer therapy.
Yan Peng, Ying Peng, Wei Zhang, Siyi Zhang, Huiqian Peng

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPS preconditioning of MSC-CM improves protection against hypoxia/reoxygenation-induced damage in H9c2 cells partly via HMGB1/Bach1 signalling.
Dan Wang, Yu Xie, Hui-Qian Peng, Zhi-Min Wen, Zi-Yue Ying

Clin Exp Pharmacol Physiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Lipopolysaccharide-pretreated mesenchymal stem cell-conditioned medium optimized with 10 kDa filter attenuates the injury of H9c2 cardiomyocytes in a model of hypoxia/reoxygenation.
Dan Wang, Jing-Yi Wen, Di Wu, Zi-Yue Ying, Zhi-Min Wen, Hui-Qian Peng

Can J Physiol Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipopolysaccharide-pretreated mesenchymal stem cell-conditioned medium optimized with 10 kDa filter attenuates the injury of H9c2 cardiomyocytes in a model of hypoxia/reoxygenation.
Dan Wang, Jing-Yi Wen, Di Wu, Zi-Yue Ying, Zhi-Min Wen, Hui-Qian Peng

Can J Physiol Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis